The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Prikhodko V.A.

Saint Petersburg State Chemical and Pharmaceutical University of the Ministry of Health of Russia

Okovityi S.V.

Saint Petersburg State Chemical and Pharmaceutical University of the Ministry of Health of Russia

Pharmacokinetic and pharmacodynamic aspects of the anti-edematous agent escin lysinate

Authors:

Prikhodko V.A., Okovityi S.V.

More about the authors

Read: 778 times


To cite this article:

Prikhodko VA, Okovityi SV. Pharmacokinetic and pharmacodynamic aspects of the anti-edematous agent escin lysinate. Russian Journal of Anesthesiology and Reanimatology. 2025;(4):81‑86. (In Russ.)
https://doi.org/10.17116/anaesthesiology202504181

References:

  1. Stokum JA, Gerzanich V, Sheth KN, Kimberly WT, Simard JM. Emerging Pharmacological Treatments for Cerebral Edema: Evidence from Clinical Studies. Annual Review of Pharmacology and Toxicology. 2020;60:291-309.  https://doi.org/10.1146/annurev-pharmtox-010919-023429
  2. Keeley V. Pharmacological treatment for chronic oedema. British Journal of Community Nursing. 2008;13(4):S4-S10.  https://doi.org/10.12968/bjcn.2008.13.Sup2.29394
  3. van den Bekerom MP, Struijs PA, Blankevoort L, Welling L, van Dijk CN, Kerkhoffs GM. What is the evidence for rest, ice, compression, and elevation therapy in the treatment of ankle sprains in adults?. Journal of Athletic Training. 2012;47(4):435-443.  https://doi.org/10.4085/1062-6050-47.4.14
  4. Geisler R, Dargel C, Hellweg T. The Biosurfactant β-Aescin: A Review on the Physico-Chemical Properties and Its Interaction with Lipid Model Membranes and Langmuir Monolayers. Molecules. 2019;25(1):117.  https://doi.org/10.3390/molecules25010117
  5. Gosudarstvennyj reestr lekarstvennykh sredstv Rossijskoj Federatsii. (In Russ.). Accessed May 25, 2025. https://grls.rosminzdrav.ru/GRLS.aspx
  6. Gallelli L. Escin: a review of its anti-edematous, anti-inflammatory, and venotonic properties. Drug Design, Development and Therapy. 2019; 13:3425-3437. https://doi.org/10.2147/DDDT.S207720
  7. Facino RM, Carini M, Stefani R, Aldini G, Saibene L. Anti-elastase and anti-hyaluronidase activities of saponins and sapogenins from Hedera helix, Aesculus hippocastanum, and Ruscus aculeatus: factors contributing to their efficacy in the treatment of venous insufficiency. Archiv der Pharmazie (Weinheim). 1995;328(10):720-724.  https://doi.org/10.1002/ardp.19953281006
  8. Marhuenda E, Alarcón de la Lastra C, Martín MJ. Antisecretory and gastroprotective effects of aescine in rats. General Pharmacology. 1994;25(6): 1213-1219. https://doi.org/10.1016/0306-3623(94)90140-6
  9. Marcianò G, Vocca C, Dıraçoğlu D, Sevgin RÖ, Gallelli L. Escin’s Action on Bradykinin Pathway: Advantageous Clinical Properties for an Unknown Mechanism?. Antioxidants (Basel). 2024;13(9):1130. https://doi.org/10.3390/antiox13091130
  10. Montopoli M, Froldi G, Comelli MC, Prosdocimi M, Caparrotta L. Aescin protection of human vascular endothelial cells exposed to cobalt chloride mimicked hypoxia and inflammatory stimuli. Planta Medica. 2007;73(3): 285-288.  https://doi.org/10.1055/s-2007-967118
  11. Zhang K, Jiang Z, Ning X, Yu X, Xu J, Buzzacott P, Xu W. Endothelia-Targeting Protection by Escin in Decompression Sickness Rats. Scientific Reports. 2017;7:41288. https://doi.org/10.1038/srep41288
  12. Domanski D, Zegrocka-Stendel O, Perzanowska A, Dutkiewicz M, Kowalewska M, Grabowska I, Maciejko D, Fogtman A, Dadlez M, Koziak K. Molecular Mechanism for Cellular Response to β-Escin and Its Therapeutic Implications. PLoS One. 2016;11(10):e0164365. https://doi.org/10.1371/journal.pone.0164365
  13. Arnould T, Janssens D, Michiels C, Remacle J. Effect of aescine on hypoxia-induced activation of human endothelial cells. European Journal of Pharmacology. 1996;315(2):227-233.  https://doi.org/10.1016/s0014-2999(96)00645-0
  14. Ji DB, Xu B, Liu JT, Ran FX, Cui JR. β-Escin sodium inhibits inducible nitric oxide synthase expression via downregulation of the JAK/STAT pathway in A549 cells. Molecular Carcinogenesis. 2011;50(12):945-960.  https://doi.org/10.1002/mc.20762
  15. Chen C, Wang S, Chen J, Liu X, Zhang M, Wang X, Xu W, Zhang Y, Li H, Pan X, Si M. Escin suppresses HMGB1-induced overexpression of aquaporin-1 and increased permeability in endothelial cells. FEBS Open Bio. 2019;9(5):891-900.  https://doi.org/10.1002/2211-5463.12622
  16. Wang B, Yang R, Ju Q, Liu S, Zhang Y, Ma Y. Clinical effects of joint application of β-sodium aescinate and mannitol in treating early swelling after upper limb trauma surgery. Experimental and Therapeutic Medicine. 2016;12(5):3320-3322. https://doi.org/10.3892/etm.2016.3743
  17. Paneerselvam C, Ganapasam S. β-Escin alleviates cobalt chloride-induced hypoxia-mediated apoptotic resistance and invasion via ROS-dependent HIF-1α/TGF-β/MMPs in A549 cells. Toxicology Research (Cambridge). 2020;9(3):191-201.  https://doi.org/10.1093/toxres/tfaa019
  18. Vašková J, Fejerčáková A, Mojžišová G, Vaško L, Patlevič P. Antioxidant potential of Aesculus hippocastanum extract and escin against reactive oxygen and nitrogen species. European Review for Medical and Pharmacological Sciences. 2015;19(5):879-886. Accessed May 25, 2025. https://pubmed.ncbi.nlm.nih.gov/25807442/
  19. Li M, Liu X, Zhou X, Meng R, Ji X. Escin Rescues Blood-brain Barrier and Inhibits NLRP3 Inflammasome-mediated Pyroptosis in Rats with Superior Sagital Sinus Thrombosis. International Journal of Medical Sciences. 2025;22(7):1602-1611. https://doi.org/10.7150/ijms.102624
  20. Li M, Lu C, Zhang L, Zhang J, Du Y, Duan S, Wang T, Fu F. Oral Administration of Escin Inhibits Acute Inflammation and Reduces Intestinal Mucosal Injury in Animal Models. Evidence-Based Complementary and Alternative Medicine. 2015;2015:503617. https://doi.org/10.1155/2015/503617
  21. Li M, Wang S, Zhang C, Chi C, Liu R, Wang T, Fu F. Escin alleviates stress-induced intestinal dysfunction to protect brain injury by regulating the gut-brain axis in ischemic stroke rats. International Immunopharmacology. 2023;115:109659. https://doi.org/10.1016/j.intimp.2022.109659
  22. Sun X, Liu Z, Zhou L, Ma R, Zhang X, Wang T, Fu F, Wang Y. Escin avoids hemorrhagic transformation in ischemic stroke by protecting BBB through the AMPK/Cav-1/MMP-9 pathway. Phytomedicine. 2023;120:155071. https://doi.org/10.1016/j.phymed.2023.155071
  23. Raffetto JD, Khalil RA. Ca(2+)-dependent contraction by the saponoside escin in rat vena cava: implications in venotonic treatment of varicose veins. Journal of Vascular Surgery. 2011;54(2):489-496.  https://doi.org/10.1016/j.jvs.2011.01.043
  24. Carrasco OF, Vidrio H. Endothelium protectant and contractile effects of the antivaricose principle escin in rat aorta. Vascular Pharmacology. 2007; 47(1):68-73.  https://doi.org/10.1016/j.vph.2007.04.003
  25. Gallelli L, Cione E, Wang T, Zhang L. Glucocorticoid-Like Activity of Escin: A New Mechanism for an Old Drug. Drug Design, Development and Therapy. 2021;15:699-704.  https://doi.org/10.2147/DDDT.S297501
  26. Jiang N, Xin W, Wang T, Zhang L, Fan H, Du Y, Li C, Fu F. Protective effect of aescin from the seeds of Aesculus hippocastanum on liver injury induced by endotoxin in mice. Phytomedicine. 2011;18(14):1276-1284. https://doi.org/10.1016/j.phymed.2011.06.011
  27. Wang H, Zhang L, Jiang N, Wang Z, Chong Y, Fu F. Anti-inflammatory effects of escin are correlated with the glucocorticoid receptor/NF-κB signaling pathway, but not the COX/PGF2α signaling pathway. Experimental and Therapeutic Medicine. 2013;6(2):419-422.  https://doi.org/10.3892/etm.2013.1128
  28. Zhao SQ, Xu SQ, Cheng J, Cao XL, Zhang Y, Zhou WP, Huang YJ, Wang J, Hu XM. Anti-inflammatory effect of external use of escin on cutaneous inflammation: possible involvement of glucocorticoids receptor. Chinese Journal of Natural Medicines. 2018;16(2):105-112.  https://doi.org/10.1016/S1875-5364(18)30036-0
  29. Xin W, Zhang L, Sun F, Jiang N, Fan H, Wang T, Li Z, He J, Fu F. Escin exerts synergistic anti-inflammatory effects with low doses of glucocorticoids in vivo and in vitro. Phytomedicine. 2011;18(4):272-277.  https://doi.org/10.1016/j.phymed.2010.08.013
  30. Park AY, Lee JO, Jang YN, Kim SY, Heo JH, Kim YJ, Lee JM, Yoon DW, Kim BJ, Seok J. Ameliorative Effects of Escin on Inflammation via Glucocorticoid Receptor (GR) in Atopic Dermatitis (AD) Mouse Model. Journal of Microbiology and Biotechnology. 2025;35:e2410025. https://doi.org/10.4014/jmb.2410.10025
  31. Annoni F, Mauri A, Marincola F, Resele LF. Venotonic activity of escin on the human saphenous vein. Arzneimittelforschung. 1979;29(4):672-675. Accessed May 25, 2025. https://pubmed.ncbi.nlm.nih.gov/582766
  32. Wang T, Fu F, Zhang L, Han B, Zhu M, Zhang X. Effects of escin on acute inflammation and the immune system in mice. Pharmacological Reports. 2009;61(4):697-704.  https://doi.org/10.1016/s1734-1140(09)70122-7
  33. Zhang L, Wang H, Fan H, Wang T, Jiang N, Yu P, Fu F. The potent anti-inflammatory agent escin does not increase corticosterone secretion and immune cell apoptosis in mice. Fitoterapia. 2011;82(6):861-867.  https://doi.org/10.1016/j.fitote.2011.04.004
  34. Elshal M, Hazem SH. Escin suppresses immune cell infiltration and selectively modulates Nrf2/HO-1, TNF-α/JNK, and IL-22/STAT3 signaling pathways in concanavalin A-induced autoimmune hepatitis in mice. Inflammopharmacology. 2022;30(6):2317-2329. https://doi.org/10.1007/s10787-022-01058-z
  35. Xu F, Jiang Y, Wang X, Shen L, Yan Y, Guo D, Wang C. Sodium aescinate inhibits microglia activation through NF-κB pathway and exerts neuroprotective effect. Frontiers in Pharmacology. 2023;14:1086429. https://doi.org/10.3389/fphar.2023.1086429
  36. Avci G, Küçükkurt I, Küpeli Akkol E, Yeşilada E. Effects of escin mixture from the seeds of Aesculus hippocastanum on obesity in mice fed a high fat diet. Pharmaceutical Biology. 2010;48(3):247-252.  https://doi.org/10.3109/13880200903085466
  37. Sharipov A, Tursunov K, Fazliev S, Azimova B, Razzokov J. Hypoglycemic and Anti-Inflammatory Effects of Triterpene Glycoside Fractions from Aeculus hippocastanum Seeds. Molecules. 2021;26(13):3784. https://doi.org/10.3390/molecules26133784
  38. Vedantam D, Poman DS, Motwani L, Asif N, Patel A, Anne KK. Stress-Induced Hyperglycemia: Consequences and Management. Cureus. 2022; 14(7):e26714. https://doi.org/10.7759/cureus.26714
  39. Wang Y, Han X, Wan X, Niu F, Zhou C. β-Escin: An Updated Review of Its Analysis, Pharmacology, Pharmacokinetics, and Toxicity. The American Journal of Chinese Medicine. 2023;51(8):2095-2120. https://doi.org/10.1142/S0192415X23500908
  40. Wu XJ, Zhang ML, Cui XY, Paul Fawcett J, Gu JK. Comparative pharmacokinetics and the bioavailability of escin Ib and isoescin Ib following the administration of escin, pure escin Ib and isoescin Ib in rats. Journal of Ethnopharmacology. 2014;151(2):839-845.  https://doi.org/10.1016/j.jep.2013.11.039
  41. Hu JN, Zhu XM, Han LK, Saito M, Sun YS, Yoshikawa M, Kimura Y, Zheng YN. Anti-obesity effects of escins extracted from the seeds of Aesculus turbinata BLUME (Hippocastanaceae). Chemical and Pharmaceutical Bulletin (Tokyo). 2008;56(1):12-16.  https://doi.org/10.1248/cpb.56.12
  42. Huang S, Wang X, Liu M, Lin Z, Gu W, Zhao H, Zhang Y, Ding B, Liu J, Wu X, Fan W, Chen J. Modification of sodium aescinate into a safer, more stable and effective water-soluble drug by liposome-encapsulation: an in vitro and in vivo study. Drug Delivery. 2022;29(1):1132-1141. https://doi.org/10.1080/10717544.2022.2058114
  43. Chukanova EI, Chukanova AS, Mamaeva KhI. Chronic cerebral venous insufficiency. Etiology, clinic, treatment. Poliklinika. 2018;(5):23-27. (In Russ.).

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.